Because PPARα is mainly expressed in liver tissue and play important roles in lipid uptake and storage of liver tissue, the regulation of hepatic PPARα is necessary for the treatment of NAFLD. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.